Pharmaceuticals

The Indian Pharmaceutical industry certainly looks forward to a blazing future today, with contract research, clinical trials businesses and contract manufacturing taking shape and the new patent regime opening new opportunities for players in the country.

The pharmaceutical products account for 8 percent of the global pharmaceutical sales and India is the fifth largest producer and exporter of bulk medicines in the world. Indian Pharmaceutical Industry is estimated to be worth $ 4.5 billion, growing at about 9 percent annually. There are 20,000 laboratories in India's pharmaceutical industry and the leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. From simple headache pills to sophisticated antibiotics and complex cardiac compounds, almost every type of medicine is now made indigenously.

The Pharmaceutical industry in India is among the most greatly organized sectors. The industry plays a vital role in promoting and sustaining development in the field of global medicine. With the presence of low cost manufacturing facilities, educated and skilled manpower and cheap labor force among others, the industry is set to scale new heights in the fields of production, development, manufacturing, outsourcing and research.

Nevertheless, it is an extremely fragmented market with severe price competition and government price control. The Pharmaceutical industry faces an array of challenges like regulatory obstacles, lack of proper infrastructure, lack of qualified professionals, expensive research equipments, lack of academic collaboration, underdeveloped molecular discovery program and divide between the industry and study curriculum which together build a high-risk operational structure for the industry.

With ENAM’s integrated risk management solutions and benchmarking capabilities, our team of pharmaceutical experts works in partnership to recognize definite business needs and offer organizations a full spectrum of services and expertise to suit their changing environment.

ENAM Risk Management Strategy

Assistance in determination of the objectives of the client company
Advice on specific and detailed risk identification, analysis and assessment
Selection of the risk treatment devices or appropriate covers from the market
Arranging for risk transfer with optimization of covers at best possible quotes
Prompt claims facilitation, cooperation and provision of technical expertise.

To know more, please feel free to write to insure@enam.com

Best Viewed with Internet Explorer 7 or higher at 1024 x 768 pixels

Enam Insurance Broker is regulated by Insurance Regulatory and Development Authority; License Code: DB – 340/06’